• 1  Elder DE, Elenitsas R, Murphy GF, Xu X. Benign pigmented lesions and melanoma. In: Elder DE, Elenitsas R, Johnson BL, Jr, Murphy GF, eds. Lever's Histopathology of the Skin, 9th edn. Philadelpia: Lippincott Williams and Wilkins, 2005:715–803.
  • 2  Bastiaens M, ter Huurne J, Gruis N, et al. The melanocortin‐1–receptor gene is the major freckle gene. Hum Mol Genet 2001;10:1701–8. Cross Ref link Pubmed link
  • 3  Bastiaens M, Hoefnagel J, Westendorp R, et al. Solar lentigines are strongly related to sun exposure in contrast to ephelides. Pigment cell research sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society. Pigment Cell Res 2004;17:225–9. Cross Ref link Pubmed link
  • 4  Olsen CM, Carroll HJ, Whiteman DC. Estimating the attributable fraction for melanoma: a meta‐analysis of pigmentary characteristics and freckling. Int J Cancer 2010;127:2430–45. Cross Ref link Pubmed link
  • 5  Guerrero D. Dermocosmetic management of hyperpigmentations. Ann Dermatol Vénéréol 2012;139(Suppl. 4):S166–9.
  • 6  Lodish MB, Stratakis CA. The differential diagnosis of familial lentiginosis syndromes. Fam Cancer 2011;10:481–90. Cross Ref link Pubmed link
  • 7  Toelle SP, Boltshauser E, Wirth MG, Itin P. Association of lentiginous mosaicism and congenital cataract in a girl. Eur J Dermatol 2006;16:360–2. Pubmed link
  • 8  Karrer S, Kohl E, Feise K, et al. Photodynamic therapy for skin rejuvenation: review and summary of the literature – results of a consensus conference of an expert group for aesthetic photodynamic therapy. J Deut Dermatol Gesellsch 2013;11:137–48.
  • 9  Chen N, Hu Y, Li WH, et al. The role of keratinocyte growth factor in melanogenesis: a possible mechanism for the initiation of solar lentigines. Exp Dermatol 2010;19:865–72. Cross Ref link Pubmed link
  • 10  Kovacs D, Cardinali G, Aspite N, et al. Role of fibroblast‐derived growth factors in regulating hyperpigmentation of solar lentigo. Br J Dermatol 2010;163:1020–7. Cross Ref link Pubmed link
  • 11  Mauerer A, Betz RC, Pasternack SM, et al. Generalized solar lentigines in a patient with a history of radon exposure. Dermatology 2010;221:206–10. Cross Ref link Pubmed link
  • 12  Hafner C, Stoehr R, van Oers JM, et al. FGFR3 and PIK3CA mutations are involved in the molecular pathogenesis of solar lentigo. Br J Dermatol 2009;160:546–51. Cross Ref link Pubmed link
  • 13  Derancourt C, Bourdon‐Lanoy E, Grob JJ, et al. Multiple large solar lentigos on the upper back as clinical markers of past severe sunburn: a case‐control study. Dermatology 2007;214:25–31. Cross Ref link Pubmed link
  • 14  Monestier S, Gaudy C, Gouvernet J, et al. Multiple senile lentigos of the face, a skin ageing pattern resulting from a life excess of intermittent sun exposure in dark‐skinned caucasians: a case‐control study. Br J Dermatol 2006;154:438–44. Cross Ref link Pubmed link
  • 15  Kim J, Taube JM, McCalmont TH, Glusac EJ. Quantitative comparison of MiTF, Melan‐A, HMB‐45 and Mel‐5 in solar lentigines and melanoma in situ. J Cutan Pathol 2011;38:775–9. Pubmed link
  • 16  Black WH, Thareja SK, Blake BP, et al. Distinction of melanoma in situ from solar lentigo on sun‐damaged skin using morphometrics and MITF immunohistochemistry. Am J Dermatopathol 2011;33:573–8. Cross Ref link Pubmed link
  • 17  Stankiewicz K, Chuang G, Avram M. Lentigines, laser, and melanoma: a case series and discussion. Laser Surg Med 2012;44:112–16. Cross Ref link
  • 18  Yamashita T, Negishi K, Hariya T, et al. In vivo microscopic approaches for facial melanocytic lesions after quality‐switched ruby laser therapy: time‐sequential imaging of melanin and melanocytes of solar lentigo in Asian skin. Dermatol Surg 2010;36:1138–47. Cross Ref link Pubmed link
  • 19  Abdullah AN, Keczkes K. Cutaneous and ocular side‐effects of PUVA photochemotherapy – a 10–year follow‐up study. Clin Exp Dermatol 1989;14:421–4. Cross Ref link Pubmed link
  • 20  Stern RS; PUVA Follow‐up Study. The risk of melanoma in association with long‐term exposure to PUVA. J Am Acad Dermatol 2001;44:755–61. Cross Ref link Pubmed link
  • 21  Rhodes AR, Stern RS, Melski JW. The PUVA lentigo: an analysis of predisposing factors. J Invest Dermatol 1983;81:459–63. Cross Ref link Pubmed link
  • 22  Friedland R, David M, Feinmesser M, et al. NB‐UVB (311–312 nm)‐induced lentigines in patients with mycosis fungoides: a new adverse effect of phototherapy. J Eur Acad Dermatol Venereol 2012;26:1158–62. Cross Ref link Pubmed link
  • 23  Nakagawa H, Rhodes AR, Momtaz TK, Fitzpatrick TB. Morphologic alterations of epidermal melanocytes and melanosomes in PUVA lentigines: a comparative ultrastructural investigation of lentigines induced by PUVA and sunlight. J Invest Dermatol 1984;82:101–7. Cross Ref link Pubmed link
  • 24  Stern RS. Risks of cancer associated with long‐term exposure to PUVA in humans: current status – 1991. Blood Cells 1992;18:91–7; discussion 8–9.
  • 25  Lindelof B, Sigurgeirsson B, Tegner E, et al. PUVA and cancer risk: the Swedish follow‐up study. Br J Dermatol 1999;141:108–12. Cross Ref link Pubmed link
  • 26  Bolognia JL. Reticulated black solar lentigo (‘ink spot’ lentigo). Arch Dermatol 1992;128:934–40. Cross Ref link Pubmed link
  • 27  Lenane P, Keane CO, Connell BO, et al. Genital melanotic macules: clinical, histologic, immunohistochemical, and ultrastructural features. J Am Acad Dermatol 2000;42:640–4. Cross Ref link Pubmed link
  • 28  Buchner A, Merrell PW, Carpenter WM. Relative frequency of solitary melanocytic lesions of the oral mucosa. J Oral Pathol Med 2004;33:550–7. Cross Ref link Pubmed link
  • 29  Meleti M, Vescovi P, Mooi WJ, van der Waal I. Pigmented lesions of the oral mucosa and perioral tissues: a flow‐chart for the diagnosis and some recommendations for the management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105:606–16. Cross Ref link Pubmed link
  • 30  Carlson JA, Mu XC, Slominski A, et al. Melanocytic proliferations associated with lichen sclerosus. Arch Dermatol 2002;138:77–87. Cross Ref link Pubmed link
  • 31  Ficarra G, Shillitoe EJ, Adler‐Storthz K, et al. Oral melanotic macules in patients infected with human immunodeficiency virus. Oral Surg Oral Med Oral Pathol 1990;70:748–55. Cross Ref link Pubmed link
  • 32  Meleti M, Leemans CR, Mooi WJ, et al. Oral malignant melanoma: a review of the literature. Oral Oncol 2007;43:116–21. Cross Ref link Pubmed link
  • 33  Gondak RO, da Silva‐Jorge R, Jorge J, et al. Oral pigmented lesions: clinicopathologic features and review of the literature. Med Oral Patol Oral Cirugia Bucal 2012;17:e919–24. Cross Ref link
  • 34  Ferrari A, Buccini P, Covello R, et al. The ringlike pattern in vulvar melanosis: a new dermoscopic clue for diagnosis. Arch Dermatol 2008;144:1030–4. Cross Ref link Pubmed link
  • 35  Rajpar SF, Marsden JR. Imiquimod in the treatment of lentigo maligna. Br J Dermatol 2006;155:653–6. Cross Ref link Pubmed link
  • 36  Kaugars GE, Heise AP, Riley WT, et al. Oral melanotic macules. A review of 353 cases. Oral Surg Oral Med Oral Pathol 1993;76:59–61. Cross Ref link Pubmed link
  • 37  Gupta G, Williams RE, Mackie RM. The labial melanotic macule: a review of 79 cases. Br J Dermatol 1997;136:772–5. Cross Ref link Pubmed link
  • 38  Gupta G, MacKay IR, MacKie RM. Q‐switched ruby laser in the treatment of labial melanotic macules. Laser Surg Med 1999;25:219–22. Cross Ref link
  • 39  Ferahbas A, Utas S, Akcakus M, et al. Prevalence of cutaneous findings in hospitalized neonates: a prospective observational study. Pediatr Dermatol 2009;26:139–42. Cross Ref link Pubmed link
  • 40  Egemen A, Ikizoglu T, Ergor S, et al. Frequency and characteristics of mongolian spots among Turkish children in Aegean region. Turk J Pediatr 2006;48:232–6. Pubmed link
  • 41  Reza AM, Farahnaz GZ, Hamideh S, et al. Incidence of Mongolian spots and its common sites at two university hospitals in Tehran, Iran. Pediatr Dermatol 2010;27:397–8. Cross Ref link Pubmed link
  • 42  Moosavi Z, Hosseini T. One‐year survey of cutaneous lesions in 1000 consecutive Iranian newborns. Pediatr Dermatol 2006;23:61–3. Cross Ref link Pubmed link
  • 43  Bilgili SG, Akdeniz N, Karadag AS, et al. Mucocutaneous disorders in children with down syndrome: case‐controlled study. Genet Counsel 2011;22:385–92. Pubmed link
  • 44  Wolf R, Wolf D, Davidovici B. Phacomatosis pigmentopigmentalis: aberrant Mongolian spots and segmental cafe au lait macules. Pediatr Dermatol 2009;26:228–9. Cross Ref link Pubmed link
  • 45  Acebo E, Gardeazabal J, Gonzalez‐Hermosa R, et al. Congenital hemangioma: a report of evolution from rapidly involuting to noninvoluting congenital hemangioma with aberrant Mongolian spots. Pediatr Dermatol 2009;26:225–6. Cross Ref link Pubmed link
  • 46  Ashrafi MR, Shabanian R, Mohammadi M, Kavusi S. Extensive Mongolian spots: a clinical sign merits special attention. Pediatr Neurol 2006;34:143–5. Cross Ref link Pubmed link
  • 47  Hackbart BA, Arita JH, Pinho RS, et al. Mongolian spots are not always a benign sign. J Pediatr 2013;162:1070. Cross Ref link Pubmed link
  • 48  Grant BP, Beard JS, de Castro F, et al. Extensive mongolian spots in an infant with Hurler syndrome. Arch Dermatol 1998;134:108–9. Cross Ref link Pubmed link
  • 49  Esterly NB, Weissbluth M, Caro WA. Mongolian spots and GM1 type 1 gangliosidosis. J Am Acad Dermatol 1990;22:320. Cross Ref link Pubmed link
  • 50  Su F, Li F, Jin HZ. Extensive Mongolian spots in a child with mucolipidosis II. Int J Dermatol 2010;49:438–40. Cross Ref link Pubmed link
  • 51  Hidano A, Kajima H, Ikeda S, et al. Natural history of nevus of Ota. Arch Dermatol 1967;95:187–95. Cross Ref link Pubmed link
  • 52  Kagami S, Asahina A, Watanabe R, et al. Laser treatment of 26 Japanese patients with Mongolian spots. Dermatol Surg 2008;34:1689–94. Pubmed link
  • 53  Kagami S, Asahina A, Uwajima Y, et al. Treatment of persistent Mongolian spots with Q‐switched alexandrite laser. Laser Medical Sci 2012;27:1229–32. Cross Ref link
  • 54  Shirakawa M, Ozawa T, Ohasi N, et al. Comparison of regional efficacy and complications in the treatment of aberrant Mongolian spots with the Q‐switched ruby laser. J Cosmetic Laser Ther 2010;12:138–42. Cross Ref link
  • 55  Aurangabadkar S. QYAG5 Q‐switched Nd:YAG laser treatment of nevus of Ota: an Indian study of 50 patients. J Cutan Aesthet Surg 2008;1:80–4. Cross Ref link Pubmed link
  • 56  Van Raamsdonk CD, Bezrookove V, Green G, et al. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 2009;457:599–602. Cross Ref link Pubmed link
  • 57  Chan HH, Lam LK, Wong DS, et al. Nevus of Ota: a new classification based on the response to laser treatment. Laser Surg Med 2001;28:267–72. Cross Ref link
  • 58  Hori Y, Takayama O. Circumscribed dermal melanoses. Classification and histologic features. Dermatol Clin 1988;6:315–26. Pubmed link
  • 59  Hirayama T, Suzuki T. A new classification of Ota's nevus based on histopathological features. Dermatologica 1991;183:169–72. Cross Ref link Pubmed link
  • 60  Hori Y, Kawashima M, Oohara K, Kukita A. Acquired, bilateral nevus of Ota‐like macules. J Am Acad Dermatol 1984;10:961–4. Cross Ref link Pubmed link
  • 61  Park JM, Tsao H, Tsao S. Acquired bilateral nevus of Ota‐like macules (Hori nevus): etiologic and therapeutic considerations. J Am Acad Dermatol 2009;61:88–93. Cross Ref link Pubmed link
  • 62  Rahimi‐Movaghar V, Karimi M. Meningeal melanocytoma of the brain and oculodermal melanocytosis (nevus of Ota): case report and literature review. Surg Neurol 2003;59:200–10. Cross Ref link Pubmed link
  • 63  Baroody M, Holds JB. Extensive locoregional malignant melanoma transformation in a patient with oculodermal melanocytosis. Plast Reconstr Surg 2004;113:317–22. Cross Ref link Pubmed link
  • 64  Sharan S, Grigg JR, Billson FA. Bilateral naevus of Ota with choroidal melanoma and diffuse retinal pigmentation in a dark skinned person. Br J Ophthalmol 2005;89:1529. Cross Ref link Pubmed link
  • 65  Wang J, Guo ZZ, Zhang SG, et al. Microsurgical treatment of meningeal malignant melanoma accompanied by nevus of Ota: two case reports and a literature review. Melanoma Res 2013;23:502–4. Cross Ref link Pubmed link
  • 66  Radhadevi CV, Charles KS, Lathika VK. Orbital malignant melanoma associated with nevus of Ota. Indian J Ophthalmol 2013;61:306–9. Cross Ref link Pubmed link
  • 67  Yang Q, Wei WB, Yang WL, et al. Choroidal malignant melanoma in patients with oculodermal melanocytosis: report of three cases. Chin Med J 2010;123:111–13. Pubmed link
  • 68  Watanabe S, Takahashi H. Treatment of nevus of Ota with the Q‐switched ruby laser. New Engl J Med 1994;331:1745–50. Cross Ref link Pubmed link
  • 69  Kar HK, Gupta L. 1064 nm Q switched Nd: YAG laser treatment of nevus of Ota: an Indian open label prospective study of 50 patients. Ind J Dermatol Venereol Leprol 2011;77:565–70. Cross Ref link
  • 70  Lu Z, Fang L, Jiao S, et al. Treatment of 522 patients with nevus of Ota with Q‐switched Alexandrite laser. Chin Med J 2003;116:226–30. Pubmed link
  • 71  Kono T, Nozaki M, Chan HH, Mikashima Y. A retrospective study looking at the long‐term complications of Q‐switched ruby laser in the treatment of nevus of Ota. Laser Surg Med 2001;29:156–9. Cross Ref link
  • 72  Mukhopadhyay AK. Unilateral nevus of Ota with bilateral nevus of Ito and palatal lesion: a case report with a proposed clinical modification of Tanino's classification. Indian J Dermatol 2013;58:286–9. Cross Ref link Pubmed link
  • 73  Seo SH, Jeong JT, Kim SN, Kye YC. A case of bilateral nevus of Ota associated with bilateral nevus of Ito.Korean J Dermatol 2001;39:106–8.
  • 74  Kim BH OY, Lee KW. Bilateral Ota nevus and bilateral Ito nevus: 2 cases of extensive dermal melanocytic nevi associated with vascular nevus. Korean J Dermatol 1981;19:503–7.
  • 75  Trindade F, Santonja C, Requena L. Bilateral nevus of Ito and nevus spilus in the same patient. J Am Acad Dermatol 2008;59:S51–2. Cross Ref link Pubmed link
  • 76  Martinez‐Penuela A, Iglesias ME, Mercado MR, Martinez‐Penuela JM. [Malignant transformation of a nevus of Ito: description of a rare case.] Actas Dermo‐sifiliograf 2011;102:817–20. Cross Ref link
  • 77  Wise SR, Capra G, Martin P, et al. Malignant melanoma transformation within a nevus of Ito. J Am Acad Dermatol 2010;62:869–74. Cross Ref link Pubmed link
  • 78  Van Krieken JH, Boom BW, Scheffer E. Malignant transformation in a naevus of Ito. A case report. Histopathology 1988;12:100–2. Pubmed link
  • 79  Happle R. Speckled lentiginous naevus: which of the two disorders do you mean? Clin Exp Dermatol 2009;34:133–5. Cross Ref link Pubmed link
  • 80  Happle R. Speckled lentiginous nevi: no longer one single disorder. Arch Dermatol 2010;146:204. Cross Ref link Pubmed link
  • 81  Torchia D. More on speckled lentiginous nevus syndrome. Dermatology 2010;221:324–5. Cross Ref link Pubmed link
  • 82  Happle R. Phacomatosis pigmentovascularis revisited and reclassified. Arch Dermatol 2005;141:385–8. Cross Ref link Pubmed link
  • 83  Happle R, Hoffmann R, Restano L, et al. Phacomatosis pigmentokeratotica: a melanocytic‐epidermal twin nevus syndrome. Am J Med Genet 1996;65:363–5. Cross Ref link Pubmed link
  • 84  Groesser L, Herschberger E, Sagrera A, et al. Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell. J Invest Dermatol 2013;133:1998–2003. Cross Ref link Pubmed link
  • 85  Vidaurri‐de la Cruz H, Happle R. Two distinct types of speckled lentiginous nevi characterized by macular versus papular speckles. Dermatology 2006;212:53–8. Cross Ref link
  • 86  Polder KD, Landau JM, Vergilis‐Kalner IJ, et al. Laser eradication of pigmented lesions: a review. Dermatol Surg 2011;37:572–95. Cross Ref link Pubmed link
  • 87  Moreno‐Arias GA, Bulla F, Vilata‐Corell JJ, Camps‐Fresneda A. Treatment of widespread segmental nevus spilus by Q‐switched alexandrite laser (755 nm, 100 nsec). Dermatol Surg 2001;27:841–3. Pubmed link
  • 88  Grevelink JM, Gonzalez S, Bonoan R, et al. Treatment of nevus spilus with the Q‐switched ruby laser. Dermatol Surg 1997;23:365–9; discussion 9–70. Pubmed link
  • 89  Gandini S, Sera F, Cattaruzza MS, et al. Meta‐analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer 2005;41:28–44. Cross Ref link Pubmed link
  • 90  Tsao H, Bevona C, Goggins W, Quinn T. The transformation rate of moles (melanocytic nevi) into cutaneous melanoma: a population‐based estimate. Arch Dermatol 2003;139:282–8. Cross Ref link Pubmed link
  • 91  Hughes BR, Cunliffe WJ, Bailey CC. Excess benign melanocytic naevi after chemotherapy for malignancy in childhood. BMJ 1989;299:88–91. Cross Ref link Pubmed link
  • 92  Szepietowski J, Wasik F, Szepietowski T, et al. Excess benign melanocytic naevi in renal transplant recipients. Dermatology 1997;194:17–19. Cross Ref link Pubmed link
  • 93  Navarini AA, Kolm I, Calvo X, et al. Trauma as triggering factor for development of melanocytic nevi. Dermatology 2010;220:291–6. Cross Ref link Pubmed link
  • 94  Zvulunov A, Wyatt DT, Laud PW, Esterly NB. Influence of genetic and environmental factors on melanocytic naevi: a lesson from Turner's syndrome. Br J Dermatol 1998;138:993–7. Cross Ref link Pubmed link
  • 95  Broberg A, Augustsson A. Atopic dermatitis and melanocytic naevi. Br J Dermatol 2000;142:306–9. Cross Ref link Pubmed link
  • 96  Synnerstad I, Nilsson L, Fredrikson M, Rosdahl I. Fewer melanocytic nevi found in children with active atopic dermatitis than in children without dermatitis. Arch Dermatol 2004;140:1471–5. Cross Ref link Pubmed link
  • 97  Martinez‐Casimiro L, Sanchez Carazo JL, Alegre V. Balloon cell naevus. J Eur Acad Dermatol Venereol 2009;23:236–7. Cross Ref link Pubmed link
  • 98  Lyall D, Srinivasan S, Roberts F. Balloon cell naevus of the conjunctiva: clinicopathological features and management. Clin Exp Ophthalmol 2011;39:271–3. Cross Ref link
  • 99  Damm DD, White DK, Lyu PE, Puno P. Balloon cell nevus of the oral mucosa. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105:755–7. Cross Ref link Pubmed link
  • 100  Yeh I, von Deimling A, Bastian BC. Clonal BRAF mutations in melanocytic nevi and initiating role of BRAF in melanocytic neoplasia. J Natl Cancer Inst 2013;105:917–19. Cross Ref link Pubmed link
  • 101  Michaloglou C, Vredeveld LC, Soengas MS, et al. BRAFE600‐associated senescence‐like cell cycle arrest of human naevi. Nature 2005;436:720–4. Cross Ref link Pubmed link
  • 102  Nan H, Xu M, Zhang J, et al. Genome‐wide association study identifies nidogen 1 (NID1) as a susceptibility locus to cutaneous nevi and melanoma risk. Hum Mol Genet 2011;20:2673–9. Cross Ref link Pubmed link
  • 103  Falchi M, Bataille V, Hayward NK, et al. Genome‐wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi. Nat Genet 2009;41:915–9. Cross Ref link Pubmed link
  • 104  Rampen FH, Fleuren BA, de Boo TM, Lemmens WA. Prevalence of common “acquired” nevocytic nevi and dysplastic nevi is not related to ultraviolet exposure. J Am Acad Dermatol 1988;18:679–83. Cross Ref link Pubmed link
  • 105  Green A, Sorahan T, Pope D, et al. Moles in Australian and British school children. Lancet 1988;2:1497. Cross Ref link Pubmed link
  • 106  Fritschi L, McHenry P, Green A, et al. Naevi in schoolchildren in Scotland and Australia. Br J Dermatol 1994;130:599–603. Cross Ref link Pubmed link
  • 107  Kelly JW, Rivers JK, MacLennan R, et al. Sunlight: a major factor associated with the development of melanocytic nevi in Australian schoolchildren. J Am Acad Dermatol 1994;30:40–8. Cross Ref link Pubmed link
  • 108  English DR, Milne E, Simpson JA. Ultraviolet radiation at places of residence and the development of melanocytic nevi in children (Australia). Cancer Causes Control 2006;17:103–7. Cross Ref link Pubmed link
  • 109  Mahe E, Beauchet A, de Paula Correa M, et al. Outdoor sports and risk of ultraviolet radiation‐related skin lesions in children: evaluation of risks and prevention. Br J Dermatol 2011;165:360–7. Cross Ref link Pubmed link
  • 110  Zalaudek I, Catricala C, Moscarella E, Argenziano G. What dermoscopy tells us about nevogenesis. J Dermatol 2011;38:16–24. Cross Ref link Pubmed link
  • 111  Mason AR, Mohr MR, Koch LH, Hood AF. Nevi of special sites. Clin Lab Med 2011;31:229–42. Cross Ref link Pubmed link
  • 112  Boyd AS, Rapini RP. Acral melanocytic neoplasms: a histologic analysis of 158 lesions. J Am Acad Dermatol 1994;31:740–5. Cross Ref link Pubmed link
  • 113  Rongioletti F, Ball RA, Marcus R, Barnhill RL. Histopathological features of flexural melanocytic nevi: a study of 40 cases. J Cutan Pathol 2000;27:215–17. Cross Ref link Pubmed link
  • 114  Fabrizi G, Pagliarello C, Parente P, Massi G. Atypical nevi of the scalp in adolescents. J Cutan Pathol 2007;34:365–9. Cross Ref link Pubmed link
  • 115  Rongioletti F, Urso C, Batolo D, et al. Melanocytic nevi of the breast: a histologic case‐control study. J Cutan Pathol 2004;31:137–40. Cross Ref link Pubmed link
  • 116  Rock B, Hood AF, Rock JA. Prospective study of vulvar nevi. J Am Acad Dermatol 1990;22:104–6. Cross Ref link Pubmed link
  • 117  Gleason BC, Hirsch MS, Nucci MR, et al. Atypical genital nevi. A clinicopathologic analysis of 56 cases. Am J Surg Pathol 2008;32:51–7. Cross Ref link Pubmed link
  • 118  Friedman RJ, Ackerman AB. Difficulties in the histologic diagnosis of melanocytic nevi on the vulvae of premenopausal women. In: Ackerman AB, ed. Pathology of Malignant Melanoma. New York: Masson, 1981:119–27.
  • 119  Sugiyama VE, Chan JK, Shin JY, et al. Vulvar melanoma: a multivariable analysis of 644 patients. Obstet Gynecol 2007;110:296–301. Cross Ref link Pubmed link
  • 120  LeBoit PE. A diagnosis for maniacs. Am J Dermatopathol 2000;22:556–8. Cross Ref link Pubmed link
  • 121  Evans MJ, Gray ES, Blessing K. Histopathological features of acral melanocytic nevi in children: study of 21 cases. Pediatr Dev Pathol 1998;1:388–92. Cross Ref link Pubmed link
  • 122  Saida T, Koga H. Dermoscopic patterns of acral melanocytic nevi: their variations, changes, and significance. Arch Dermatol 2007;143:1423–6. Pubmed link
  • 123  Shields CL, Demirci H, Karatza E, Shields JA. Clinical survey of 1643 melanocytic and nonmelanocytic conjunctival tumors. Ophthalmology 2004;111:1747–54. Cross Ref link Pubmed link
  • 124  Thiagalingam S, Johnson MM, Colby KA, Zembowicz A. Juvenile conjunctival nevus: clinicopathologic analysis of 33 cases. Am J Surg Pathol 2008;32:399–406. Cross Ref link Pubmed link
  • 125  Zembowicz A, Mandal RV, Choopong P. Melanocytic lesions of the conjunctiva. Arch Pathol Lab Med 2010;134:1785–92. Pubmed link
  • 126  Grin JM, Grant‐Kels JM, Grin CM, et al. Ocular melanomas and melanocytic lesions of the eye. J Am Acad Dermatol 1998;38:716–30. Cross Ref link Pubmed link
  • 127  Farber M, Schutzer P, Mihm MC, Jr. Pigmented lesions of the conjunctiva. J Am Acad Dermatol 1998;38:971–8. Cross Ref link Pubmed link
  • 128  Tosti A, Baran R, Piraccini BM, et al. Nail matrix nevi: a clinical and histopathologic study of twenty‐two patients. J Am Acad Dermatol 1996;34:765–71. Cross Ref link Pubmed link
  • 129  Braun RP, Baran R, Le Gal FA, et al. Diagnosis and management of nail pigmentations. J Am Acad Dermatol 2007;56:835–47. Cross Ref link Pubmed link
  • 130  Thomas L, Dalle S. Dermoscopy provides useful information for the management of melanonychia striata. Dermatol Ther 2007;20:3–10. Cross Ref link Pubmed link
  • 131  Altamura D, Altobelli E, Micantonio T, et al. Dermoscopic patterns of acral melanocytic nevi and melanomas in a white population in central Italy. Arch Dermatol 2006;142:1123–8. Cross Ref link Pubmed link
  • 132  Larre Borges A, Zalaudek I, Longo C, et al. Melanocytic nevi with special features: clinical‐dermoscopic and reflectance confocal microscopic‐findings. J Eur Acad Dermatol Venereol 2013, doi: 10.1111/jdv.12291.
  • 133  Scolyer RA, Zhuang L, Palmer AA, et al. Combined naevus: a benign lesion frequently misdiagnosed both clinically and pathologically as melanoma. Pathology 2004;36:419–27. Cross Ref link Pubmed link
  • 134  Strungs I. Common and uncommon variants of melanocytic naevi. Pathology 2004;36:396–403. Cross Ref link Pubmed link
  • 135  De Giorgi V, Massi D, Salvini C, et al. Dermoscopic features of combined melanocytic nevi. J Cutan Pathol 2004;31:600–4. Cross Ref link Pubmed link
  • 136  Argenziano G. Dermoscopy of melanocytic neoplasms: targetoid combined blue nevi. Arch Dermatol 2004;140:1576. Pubmed link
  • 137  King R, Hayzen BA, Page RN, et al. Recurrent nevus phenomenon: a clinicopathologic study of 357 cases and histologic comparison with melanoma with regression. Mod Pathol 2009;22:611–17. Cross Ref link Pubmed link
  • 138  Fox JC, Reed JA, Shea CR. The recurrent nevus phenomenon: a history of challenge, controversy, and discovery. Arch Pathol Lab Med 2011;135:842–6. Pubmed link
  • 139  Kornberg R, Ackerman AB. Pseudomelanoma: recurrent melanocytic nevus following partial surgical removal. Arch Dermatol 1975;111:1588–90. Cross Ref link Pubmed link
  • 140  Marghoob AA, Changchien L, DeFazio J, et al. The most common challenges in melanoma diagnosis and how to avoid them. Australas J Dermatol 2009;50:1–13; quiz 4–5. Cross Ref link
  • 141  Botella‐Estrada R, Nagore E, Sopena J, et al. Clinical, dermoscopy and histological correlation study of melanotic pigmentations in excision scars of melanocytic tumours. Br J Dermatol 2006;154:478–84. Cross Ref link Pubmed link
  • 142  Blum A, Hofmann‐Wellenhof R, Marghoob AA, et al. Recurrent melanocytic nevi and melanomas in dermoscopy: results of a multicenter study of the International Dermoscopy Society. JAMA Dermatol 2014;150:138–45. Cross Ref link Pubmed link
  • 143  Baranda L, Torres‐Alvarez B, Moncada B, et al. Presence of activated lymphocytes in the peripheral blood of patients with halo nevi. J Am Acad Dermatol 1999;41:567–72. Pubmed link
  • 144  Herd RM, Hunter JA. Familial halo naevi. Clin Exp Dermatol 1998;23:68–9. Cross Ref link Pubmed link
  • 145  Libon F, Arrese JE, Rorive A, Nikkels AF. Ipilimumab induces simultaneous regression of melanocytic naevi and melanoma metastases. Clin Exp Dermatol 2013;38:276–9. Cross Ref link Pubmed link
  • 146  Pustisek N, Sikanic‐Dugic N, Hirsl‐Hecej V, Domljan ML. “Halo nevi” and UV radiation. Collegium Antropol 2010;34(Suppl. 2):295–7.
  • 147  Aouthmany M, Weinstein M, Zirwas MJ, Brodell RT. The natural history of halo nevi: a retrospective case series.J Am Acad Dermatol 2012;67:582–6. Cross Ref link Pubmed link
  • 148  Kolm I, Di Stefani A, Hofmann‐Wellenhof R, et al. Dermoscopy patterns of halo nevi. Arch Dermatol 2006;142:1627–32. Cross Ref link Pubmed link
  • 149  Meyerson LB. A peculiar papulosquamous eruption involving pigmented nevi. Arch Dermatol 1971;103:510–12. Cross Ref link Pubmed link
  • 150  Crovato F, Nazzari G, Gambini C, Massone L. Meyerson's naevi in pityriasis rosea. Br J Dermatol 1989;120:318–19. Cross Ref link Pubmed link
  • 151  Weedon D, Farnsworth J. Spongiotic changes in melanocytic nevi. Am J Dermatopathol 1984;6(Suppl.):257–9. Pubmed link
  • 152  Brenan J, Kossard S, Krivanek J. Halo eczema around melanocytic nevi. Int J Dermatol 1985;24:226–9. Cross Ref link Pubmed link
  • 153  Conde‐Taboada A, de la Torre C, Feal C, et al. Meyerson's naevi induced by interferon alfa plus ribavirin combination therapy in hepatitis C infection. Br J Dermatol 2005;153:1070–2. Cross Ref link Pubmed link
  • 154  Krischer J, Pechere M, Salomon D, et al. Interferon alfa‐2b‐induced Meyerson's nevi in a patient with dysplastic nevus syndrome. J Am Acad Dermatol 1999;40:105–6. Cross Ref link Pubmed link
  • 155  Petit A, Viney C, Gaulier A, Sigal M. Coexistence of Meyerson's with Sutton's naevus after sunburn. Dermatology 1994;189:269–70. Cross Ref link Pubmed link
  • 156  Tegner E, Bjornberg A, Jonsson N. Halo dermatitis around tumours. Acta Dermato‐venereol 1990;70:31–4.
  • 157  Rolland S, Kokta V, Marcoux D. Meyerson phenomenon in children: observation in five cases of congenital melanocytic nevi. Pediatr Dermatol 2009;26:292–7. Cross Ref link Pubmed link
  • 158  Ramon R, Silvestre JF, Betlloch I, et al. Progression of Meyerson's naevus to Sutton's naevus. Dermatology 2000;200:337–8. Cross Ref link Pubmed link
  • 159  Fernandez‐Flores A. Eponyms, morphology, and pathogenesis of some less mentioned types of melanocytic nevi. Am J Dermatopathol 2012;34:607–18. Cross Ref link Pubmed link
  • 160  Guzzo C, Johnson B, Honig P. Cockarde nevus: a case report and review of the literature. Pediatr Dermatol 1988;5:250–3. Cross Ref link Pubmed link
  • 161  James MP, Wells RS. Cockade naevus: an unusual variant of the benign cellular naevus. Acta Dermato‐venereol 1980;60:360–3.
  • 162  Warin AP. Cockarde naevus. Clin Exp Dermatol 1976;1:221–4. Cross Ref link Pubmed link
  • 163  Bondi EE, Elder D, Guerry DT, Clark WH, Jr. Target blue nevus. Arch Dermatol 1983;119:919–20. Cross Ref link Pubmed link
  • 164  Champion RH. An unusual melanoma. Br J Dermatol 1964;76:347. Pubmed link
  • 165  Kessides MC, Puttgen KB, Cohen BA. No biopsy needed for eclipse and cockade nevi found on the scalps of children. Arch Dermatol 2009;145:1334–6. Cross Ref link Pubmed link
  • 166  Tcheung WJ, Bellet JS, Prose NS, et al. Clinical and dermoscopic features of 88 scalp naevi in 39 children. Br J Dermatol 2011;165:137–43. Cross Ref link Pubmed link
  • 167  Patrizi A, Giacomini F, Savoia F, et al. Targetoid hemosiderotic naevus. J Eur Acad Dermatol Venereol 2009;23:493–4. Cross Ref link Pubmed link
  • 168  Tomasini C, Broganelli P, Pippione M. Targetoid hemosiderotic nevus. A trauma‐induced simulator of malignant melanoma. Dermatology 2005;210:200–5. Cross Ref link Pubmed link
  • 169  Kovacs S, Megahed M. [Targetoid hemosiderotic nevus. A melanoma simulator.] Hautarzt 2007;58:931–2. Cross Ref link Pubmed link
  • 170  Spitz S. Melanomas of childhood. Am J Pathol 1948;24:591–609. Pubmed link
  • 171  Barnhill RL, Argenyi ZB, From L, et al. Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum Pathol 1999;30:513–20. Cross Ref link Pubmed link
  • 172  Luo S, Sepehr A, Tsao H. Spitz nevi and other Spitzoid lesions part I. Background and diagnoses. J Am Acad Dermatol 2011;65:1073–84. Cross Ref link Pubmed link
  • 173  Smith KJ, Barrett TL, Skelton HG, 3rd, et al. Spindle cell and epithelioid cell nevi with atypia and metastasis (malignant Spitz nevus). Am J Surg Pathol 1989;13:931–9. Cross Ref link Pubmed link
  • 174  Mones JM, Ackerman AB. “Atypical” Spitz's nevus, “malignant” Spitz's nevus, and “metastasizing” Spitz's nevus: a critique in historical perspective of three concepts flawed fatally. Am J Dermatopathol 2004;26:310–33. Cross Ref link Pubmed link
  • 175  Barnhill RL, Gupta K. Unusual variants of malignant melanoma. Clin Dermatol 2009;27:564–87. Cross Ref link Pubmed link
  • 176  Casso EM, Grin‐Jorgensen CM, Grant‐Kels JM. Spitz nevi. J Am Acad Dermatol 1992;27:901–13. Cross Ref link Pubmed link
  • 177  Ferrara G, Argenziano G, Soyer HP, et al. The spectrum of Spitz nevi: a clinicopathologic study of 83 cases. Arch Dermatol 2005;141:1381–7. Cross Ref link Pubmed link
  • 178  Cesinaro AM, Foroni M, Sighinolfi P, et al. Spitz nevus is relatively frequent in adults: a clinico‐pathologic study of 247 cases related to patient's age. Am J Dermatopathol 2005;27:469–75. Cross Ref link Pubmed link
  • 179  Dal Pozzo V, Benelli C, Restano L, et al. Clinical review of 247 case records of Spitz nevus (epithelioid cell and/or spindle cell nevus). Dermatology 1997;194:20–5. Cross Ref link Pubmed link
  • 180  Weedon D, Little JH. Spindle and epithelioid cell nevi in children and adults. A review of 211 cases of the Spitz nevus. Cancer 1977;40:217–25. Cross Ref link Pubmed link
  • 181  Miteva M, Lazova R. Spitz nevus and atypical spitzoid neoplasm. Semin Cutan Med Surg 2010;29:165–73. Cross Ref link Pubmed link
  • 182  Berlingeri‐Ramos AC, Morales‐Burgos A, Sanchez JL, Nogales EM. Spitz nevus in a Hispanic population: a clinicopathological study of 130 cases. Am J Dermatopathol 2010;32:267–75. Pubmed link
  • 183  Bar M. Spitz and Reed nevi: acquired or congenital? Dermatol Pract Concept 2012;2:203–5.
  • 184  Ackerman AB, Elish D, Shami S. Spitz's Nevus: Reassessment Critical, Revision Radical. New York: Ardor Scribendi, 2007.
  • 185  Harris MN, Hurwitz RM, Buckel LJ, Gray HR. Congenital spitz nevus. Dermatol Surg 2000;26:931–5. Cross Ref link Pubmed link
  • 186  Busam KJ, Barnhill RL. Pagetoid Spitz nevus. Intraepidermal Spitz tumor with prominent pagetoid spread. Am J Surg Pathol 1995;19:1061–7. Cross Ref link Pubmed link
  • 187  Kamino H, Misheloff E, Ackerman AB, et al. Eosinophilic globules in Spitz's nevi: new findings and a diagnostic sign. Am J Dermatopathol 1979;1:323–4. Cross Ref link Pubmed link
  • 188  Wesselmann U, Becker LR, Brocker EB, et al. Eosinophilic globules in spitz nevi: no evidence for apoptosis. Am J Dermatopathol 1998;20:551–4. Cross Ref link Pubmed link
  • 189  Spatz A, Calonje E, Handfield‐Jones S, Barnhill RL. Spitz tumors in children: a grading system for risk stratification. Arch Dermatol 1999;135:282–5. Cross Ref link Pubmed link
  • 190  Berk DR, LaBuz E, Dadras SS, et al. Melanoma and melanocytic tumors of uncertain malignant potential in children, adolescents and young adults – the Stanford experience 1995–2008. Pediatr Dermatol 2010;27:244–54. Cross Ref link Pubmed link
  • 191  Sade S, Al Habeeb A, Ghazarian D. Spindle cell melanocytic lesions – part I: an approach to compound naevoidal pattern lesions with spindle cell morphology and Spitzoid pattern lesions. J Clin Pathol 2010;63:296–321. Cross Ref link Pubmed link
  • 192  Dhouib RS, Sassi S, Jbeli A, et al. Desmoplastic spitz nevus: report of a case and review of the literature. Pathologica 2008;100:181–4. Pubmed link
  • 193  Kanter‐Lewensohn L, Hedblad MA, Wejde J, Larsson O. Immunohistochemical markers for distinguishing Spitz nevi from malignant melanomas. Mod Pathol 1997;10:917–20. Pubmed link
  • 194  Bergman R, Dromi R, Trau H, et al. The pattern of HMB‐45 antibody staining in compound Spitz nevi. Am J Dermatopathol 1995;17:542–6. Cross Ref link Pubmed link
  • 195  Rode J, Williams RA, Jarvis LR, et al. S100 protein, neurone specific enolase, and nuclear DNA content in Spitz naevus.J Pathol 1990;161:41–5. Cross Ref link Pubmed link
  • 196  Ribe A, McNutt NS. S100A6 protein expression is different in Spitz nevi and melanomas. Mod Pathol 2003;16:505–11. Cross Ref link Pubmed link
  • 197  Hilliard NJ, Krahl D, Sellheyer K. p16 expression differentiates between desmoplastic Spitz nevus and desmoplastic melanoma. J Cutan Pathol 2009;36:753–9. Cross Ref link Pubmed link
  • 198  Bastian BC, Wesselmann U, Pinkel D, Leboit PE. Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. J Invest Dermatol 1999;113:1065–9. Cross Ref link Pubmed link
  • 199  Bastian BC, LeBoit PE, Pinkel D. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol 2000;157:967–72. Cross Ref link Pubmed link
  • 200  Indsto JO, Kumar S, Wang L, et al. Low prevalence of RAS‐RAF‐activating mutations in Spitz melanocytic nevi compared with other melanocytic lesions. J Cutan Pathol 2007;34:448–55. Cross Ref link Pubmed link
  • 201  Van Engen‐van Grunsven AC, van Dijk MC, Ruiter DJ, et al. HRAS‐mutated Spitz tumors: a subtype of Spitz tumors with distinct features. Am J Surg Pathol 2010;34:1436–41. Cross Ref link Pubmed link
  • 202  Da Forno PD, Pringle JH, Fletcher A, et al. BRAF, NRAS and HRAS mutations in spitzoid tumours and their possible pathogenetic significance. Br J Dermatol 2009;161:364–72. Cross Ref link Pubmed link
  • 203  Shen L, Cooper C, Bajaj S, et al. Atypical spitz tumors with 6q23 deletions: a clinical, histological, and molecular study. Am J Dermatopathol 2013;35:804–12. Cross Ref link Pubmed link
  • 204  Yazdan P, Cooper C, Sholl LM, et al. Comparative analysis of atypical Spitz tumors with heterozygous versus homozygous 9p21 deletions for clinical outcomes, histomorphology, BRAF mutation, and p16 expression. Am J Surg Pathol 2014;38:638–45. Cross Ref link Pubmed link
  • 205  Wiesner T, Obenauf AC, Murali R, et al. Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet 2011;43:1018–21. Cross Ref link Pubmed link
  • 206  Wiesner T, Murali R, Fried I, et al. A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression. Am J Surg Pathol 2012;36:818–30. Cross Ref link Pubmed link
  • 207  Argenziano G, Agozzino M, Bonifazi E, et al. Natural evolution of Spitz nevi. Dermatology 2011;222:256–60. Cross Ref link Pubmed link
  • 208  Schmoeckel C, Wildi G, Schafer T. Spitz nevus versus malignant melanoma: spitz nevi predominate on the thighs in patients younger than 40 years of age, melanomas on the trunk in patients 40 years of age or older. J Am Acad Dermatol 2007;56:753–8. Cross Ref link Pubmed link
  • 209  Reed RJ, Ichinose H, Clark WH, Jr, Mihm MC, Jr. Common and uncommon melanocytic nevi and borderline melanomas. Semin Oncol 1975;2:119–47. Pubmed link
  • 210  Smith SA, Day CL, Jr, Vander Ploeg DE. Eruptive widespread Spitz nevi. J Am Acad Dermatol 1986;15:1155–9. Cross Ref link Pubmed link
  • 211  Fass J, Grimwood RE, Kraus E, Hyman J. Adult onset of eruptive widespread Spitz's nevi. J Am Acad Dermatol 2002;46:S142–3. Cross Ref link Pubmed link
  • 212  Paties CT, Borroni G, Rosso R, Vassallo G. Relapsing eruptive multiple Spitz nevi or metastatic spitzoid malignant melanoma? Am J Dermatopathol 1987;9:520–7. Cross Ref link Pubmed link
  • 213  Sarin KY, Sun BK, Bangs CD, et al. Activating HRAS mutation in agminated Spitz nevi arising in a nevus spilus. JAMA Dermatol 2013;149:1077–81. Cross Ref link Pubmed link
  • 214  Stern JB. Recurrent Spitz's nevi. A clinicopathologic investigation. Am J Dermatopathol 1985;7(Suppl.):49–50. Cross Ref link Pubmed link
  • 215  Ludgate MW, Fullen DR, Lee J, et al. The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution. Cancer 2009;115:631–41. Cross Ref link Pubmed link
  • 216  Sepehr A, Chao E, Trefrey B, et al. Long‐term outcome of Spitz‐type melanocytic tumors. Arch Dermatol 2011;147:1173–9. Cross Ref link Pubmed link
  • 217  Cochran AJ, Binder S, Morton DL. The role of lymphatic mapping and sentinel node biopsy in the management of atypical and anomalous melanocytic lesions. J Cutan Pathol 2010;37(Suppl. 1):54–9. Cross Ref link Pubmed link
  • 218  Murali R, Sharma RN, Thompson JF, et al. Sentinel lymph node biopsy in histologically ambiguous melanocytic tumors with spitzoid features (so‐called atypical spitzoid tumors). Ann Surg Oncol 2008;15:302–9. Cross Ref link Pubmed link
  • 219  Ghazi B, Carlson GW, Murray DR, et al. Utility of lymph node assessment for atypical spitzoid melanocytic neoplasms. Ann Surg Oncol 2010;17:2471–5. Cross Ref link Pubmed link
  • 220  Urso C, Borgognoni L, Saieva C, et al. Sentinel lymph node biopsy in patients with “atypical Spitz tumors.” A report on 12 cases. Hum Pathol 2006;37:816–23. Cross Ref link Pubmed link
  • 221  Su LD, Fullen DR, Sondak VK, et al. Sentinel lymph node biopsy for patients with problematic spitzoid melanocytic lesions: a report on 18 patients. Cancer 2003;97:499–507. Cross Ref link Pubmed link
  • 222  Crotty KA, Scolyer RA, Li L, et al. Spitz naevus versus Spitzoid melanoma: when and how can they be distinguished? Pathology 2002;34:6–12. Cross Ref link Pubmed link
  • 223  Peris K, Ferrari A, Argenziano G, et al. Dermoscopic classification of Spitz/Reed nevi. Clin Dermatol 2002;20:259–62. Cross Ref link Pubmed link
  • 224  Ferrara G, Gianotti R, Cavicchini S, et al. Spitz nevus, Spitz tumor, and spitzoid melanoma: a comprehensive clinicopathologic overview. Dermatol Clin 2013;31:589–98, viii. Cross Ref link Pubmed link
  • 225  Murphy ME, Boyer JD, Stashower ME, Zitelli JA. The surgical management of Spitz nevi. Dermatol Surg 2002;28:1065–9; discussion 9. Pubmed link
  • 226  Gambini C, Rongioletti F. Recurrent Spitz nevus. Case report and review of the literature. Am J Dermatopathol 1994;16:409–13. Cross Ref link Pubmed link
  • 227  Nino M, Brunetti B, Delfino S, et al. Spitz nevus: follow‐up study of 8 cases of childhood starburst type and proposal for management. Dermatology 2009;218:48–51. Cross Ref link Pubmed link
  • 228  Brunetti B, Nino M, Sammarco E, Scalvenzi M. Spitz naevus: a proposal for management. J Eur Acad Dermatol Venereol 2005;19:391–3. Cross Ref link Pubmed link
  • 229  Luo S, Sepehr A, Tsao H. Spitz nevi and other Spitzoid lesions part II. Natural history and management. J Am Acad Dermatol 2011;65:1087–92. Cross Ref link Pubmed link
  • 230  Zembowicz A, Phadke PA. Blue nevi and variants: an update. Arch Pathol Lab Med 2011;135:327–36. Pubmed link
  • 231  Seab JA, Jr, Graham JH, Helwig EB. Deep penetrating nevus. Am J Surg Pathol 1989;13:39–44. Cross Ref link Pubmed link
  • 232  Bender RP, McGinniss MJ, Esmay P, et al. Identification of HRAS mutations and absence of GNAQ or GNA11 mutations in deep penetrating nevi. Mod Pathol 2013;26:1320–8. Cross Ref link Pubmed link
  • 233  Kang DS, Chung KY. Common blue naevus with satellite lesions: possible perivascular dissemination resulting in a clinical resemblance to malignant melanoma. Br J Dermatol 1999;141:922–5. Cross Ref link Pubmed link
  • 234  Mones JM, Ackerman AB. “Atypical” blue nevus, “malignant” blue nevus, and “metastasizing” blue nevus: a critique in historical perspective of three concepts flawed fatally. Am J Dermatopathol 2004;26:407–30. Cross Ref link Pubmed link
  • 235  Martin RC, Murali R, Scolyer RA, et al. So‐called “malignant blue nevus”: a clinicopathologic study of 23 patients. Cancer 2009;115:2949–55. Cross Ref link Pubmed link
  • 236  Clark WH, Jr, Reimer RR, Greene M, et al. Origin of familial malignant melanomas from heritable melanocytic lesions. ‘The B‐K mole syndrome’. Arch Dermatol 1978;114:732–8. Cross Ref link Pubmed link
  • 237  Lynch HT, Frichot BC, 3rd, Lynch JF. Familial atypical multiple mole‐melanoma syndrome. J Med Genet 1978;15:352–6. Cross Ref link Pubmed link
  • 238  Elder DE, Goldman LI, Goldman SC, et al. Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma. Cancer 1980;46:1787–94. Cross Ref link Pubmed link
  • 239  Greene MH, Clark WH, Jr, Tucker MA, et al. Precursor naevi in cutaneous malignant melanoma: a proposed nomenclature. Lancet 1980;2:1024. Cross Ref link Pubmed link
  • 240  Friedman RJ, Farber MJ, Warycha MA. The ‘‘dysplastic’' nevus. Clin Dermatol 2009;27:103–15. Cross Ref link Pubmed link
  • 241  Naeyaert JM, Brochez L. Clinical practice. Dysplastic nevi. New Engl J Med 2003;349:2233–40. Cross Ref link Pubmed link
  • 242  Duffy K, Grossman D. The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects. J Am Acad Dermatol 2012;67:e1–16; quiz 7–8. Cross Ref link
  • 243  Tucker MA, Halpern A, Holly EA, et al. Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. JAMA 1997;277:1439–44. Cross Ref link Pubmed link
  • 244  Carey WP, Jr, Thompson CJ, Synnestvedt M, et al. Dysplastic nevi as a melanoma risk factor in patients with familial melanoma. Cancer 1994;74:3118–25. Cross Ref link Pubmed link
  • 245  Burden AD, Newell J, Andrew N, et al. Genetic and environmental influences in the development of multiple primary melanoma. Arch Dermatol 1999;135:261–5. Cross Ref link Pubmed link
  • 246  Titus‐Ernstoff L, Perry AE, Spencer SK, et al. Multiple primary melanoma: two‐year results from a population‐based study. Arch Dermatol 2006;142:433–8. Pubmed link
  • 247  Marghoob AA, Slade J, Kopf AW, et al. Risk of developing multiple primary cutaneous melanomas in patients with the classic atypical‐mole syndrome: a case‐control study. Br J Dermatol 1996;135:704–11. Cross Ref link Pubmed link
  • 248  Ferrone CR, Ben Porat L, Panageas KS, et al. Clinicopathological features of and risk factors for multiple primary melanomas. JAMA 2005;294:1647–54. Cross Ref link Pubmed link
  • 249  Tucker MA, Fraser MC, Goldstein AM, et al. Risk of melanoma and other cancers in melanoma‐prone families. J Invest Dermatol 1993;100:S350–5. Cross Ref link
  • 250  Zhu G, Duffy DL, Eldridge A, et al. A major quantitative‐trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum‐likelihood combined linkage and association analysis in twins and their sibs. Am J Hum Genet 1999;65:483–92. Cross Ref link Pubmed link
  • 251  Carli P, Biggeri A, Nardini P, et al. Epidemiology of atypical melanocytic naevi: an analytical study in a Mediterranean population. Eur J Cancer Prev 1997;6:506–11. Cross Ref link Pubmed link
  • 252  Braun‐Falco M, Hein R, Ring J, McNutt NS. Histopathological characteristics of small diameter melanocytic naevi. J Clin Pathol 2003;56:459–64. Cross Ref link Pubmed link
  • 253  Elder DE, Green MH, Guerry DT, et al. The dysplastic nevus syndrome: our definition. Am J Dermatopathol 1982;4:455–60. Cross Ref link Pubmed link
  • 254  Clemente C, Cochran AJ, Elder DE, et al. Histopathologic diagnosis of dysplastic nevi: concordance among pathologists convened by the World Health Organization Melanoma Programme. Hum Pathol 1991;22:313–19. Cross Ref link Pubmed link
  • 255  De Wit PE, van't Hof‐Grootenboer B, Ruiter DJ, et al. Validity of the histopathological criteria used for diagnosing dysplastic naevi. An interobserver study by the pathology subgroup of the EORTC Malignant Melanoma Cooperative Group. Eur J Cancer 1993;29A:831–9. Cross Ref link Pubmed link
  • 256  Shea CR, Vollmer RT, Prieto VG. Correlating architectural disorder and cytologic atypia in Clark (dysplastic) melanocytic nevi. Hum Pathol 1999;30:500–5. Cross Ref link Pubmed link
  • 257  National Institutes of Health. Consensus Development Conference Statement on Diagnosis and Treatment of Early Melanoma, January 27–29, 1992. Am J Dermatopathol 1993;15:34–43; discussion 6–51. Cross Ref link Pubmed link
  • 258  Duffy K, Grossman D. The dysplastic nevus: from historical perspective to management in the modern era: part II. Molecular aspects and clinical management. J Am Acad Dermatol 2012;67:19.e1–2; quiz 31–2. Cross Ref link Pubmed link
  • 259  Bauer J, Bastian BC. Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool. Dermatol Ther 2006;19:40–9. Cross Ref link Pubmed link
  • 260  Uribe P, Andrade L, Gonzalez S. Lack of association between BRAF mutation and MAPK ERK activation in melanocytic nevi. J Invest Dermatol 2006;126:161–6. Cross Ref link Pubmed link
  • 261  Hussein MR. Melanocytic dysplastic naevi occupy the middle ground between benign melanocytic naevi and cutaneous malignant melanomas: emerging clues. J Clin Pathol 2005;58:453–6. Cross Ref link Pubmed link
  • 262  Hussein MR, Roggero E, Sudilovsky EC, et al. Alterations of mismatch repair protein expression in benign melanocytic nevi, melanocytic dysplastic nevi, and cutaneous malignant melanomas. Am J Dermatopathol 2001;23:308–14. Cross Ref link Pubmed link
  • 263  Hussein MR, Sun M, Tuthill RJ, et al. Comprehensive analysis of 112 melanocytic skin lesions demonstrates microsatellite instability in melanomas and dysplastic nevi, but not in benign nevi. J Cutan Pathol 2001;28:343–50. Cross Ref link Pubmed link
  • 264  Kennedy C, Bajdik CD, Willemze R, et al. The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer. J Invest Dermatol 2003;120:1087–93. Cross Ref link Pubmed link
  • 265  Elder DE. Precursors to melanoma and their mimics: nevi of special sites. Mod Pathol 2006;19(Suppl. 2):S4–20. Cross Ref link Pubmed link
  • 266  Arumi‐Uria M, McNutt NS, Finnerty B. Grading of atypia in nevi: correlation with melanoma risk. Mod Pathol 2003;16:764–71. Cross Ref link Pubmed link
  • 267  Grichnik JM. Dermoscopy of melanocytic neoplasms: subpatterns of dysplastic/atypical nevi. Arch Dermatol 2003;139:1238. Pubmed link
  • 268  Grichnik JM. Dermoscopy of melanocytic neoplasms: subpatterns of dysplastic/atypical nevi. Arch Dermatol 2003;139:970. Pubmed link
  • 269  Grichnik JM. Dermoscopy of melanocytic neoplasms: subpatterns of dysplastic/atypical nevi. Arch Dermatol 2004;140:142. Pubmed link
  • 270  Hofmann‐Wellenhof R, Blum A, Wolf IH, et al. Dermoscopic classification of atypical melanocytic nevi (Clark nevi). Arch Dermatol 2001;137:1575–80. Pubmed link
  • 271  Annessi G, Bono R, Sampogna F, et al. Sensitivity, specificity, and diagnostic accuracy of three dermoscopic algorithmic methods in the diagnosis of doubtful melanocytic lesions: the importance of light brown structureless areas in differentiating atypical melanocytic nevi from thin melanomas. J Am Acad Dermatol 2007;56:759–67. Cross Ref link Pubmed link
  • 272  Barnhill RL. The Spitzoid lesion: rethinking Spitz tumors, atypical variants, ‘Spitzoid melanoma’ and risk assessment. Mod Pathol 2006;19(Suppl. 2):S21–33. Cross Ref link Pubmed link